OBI Pharma Stock Skyrockets After New Bile Duct Cancer Drug Earns Orphan Designation
Pharmaceutical Business News
Stay informed with the latest stories in Pharmaceutical Business
Hauding's OBI-902 ADC Receives FDA Orphan Drug Designation for Rare Bile Duct Cancer
Bao Rui's Core Business Rebounds as CDMO Orders Soar to Record High
FDA Imposes Black Box Warning on Sarepta's Gene Therapy After Two Fatalities
Taiwan Biotech Firm Soars on $152 Million Breast Cancer Drug Deal
Pfizer's $10B Metsera Acquisition: CEO Bourla Claims Obesity Market Edge
Pfizer Aims to Enter Competitive GLP-1 Drug Market by 2028
Taikang Biotech Soars on $152M Breast Cancer Drug Licensing Deal with Sandoz
You're all caught up!